Camilla Sylvest
Director/Board Member bei ARGENX SE
Vermögen: 88 962 $ am 31.03.2024
Profil
Camilla Sylvest is currently serving as the Vice Chairman at World Diabetes Foundation and as an Independent Director at Danish Crown A.
She is also an Independent Non-Executive Director at argenx SE and holds the position of EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A.
Additionally, she is the Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH.
In terms of education, Ms. Sylvest graduated from the University of Southern Denmark in 1998 and obtained an MBA from the Scandinavian International Management Institute in 2003.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARGEN-X SE
0,00% | 20.02.2024 | 225 ( 0,00% ) | 88 962 $ | 31.03.2024 |
Aktive Positionen von Camilla Sylvest
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01.01.2003 |
| ARGENX SE | Director/Board Member | 08.09.2022 |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 18.10.2011 |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Director/Board Member | - |
| World Diabetes Foundation | Director/Board Member | - |
Ausbildung von Camilla Sylvest
| University of Southern Denmark | Graduate Degree |
| Scandinavian International Management Institute | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ARGENX SE | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
| World Diabetes Foundation | Miscellaneous |
